DK151959C - Analogifremgangsmaade til fremstilling af 3-methyl-4-halogenisoxazol-5-yl-methylenoxyguanidin eller farmakologisk acceptable syreadditionssalte deraf - Google Patents

Analogifremgangsmaade til fremstilling af 3-methyl-4-halogenisoxazol-5-yl-methylenoxyguanidin eller farmakologisk acceptable syreadditionssalte deraf

Info

Publication number
DK151959C
DK151959C DK023087A DK23087A DK151959C DK 151959 C DK151959 C DK 151959C DK 023087 A DK023087 A DK 023087A DK 23087 A DK23087 A DK 23087A DK 151959 C DK151959 C DK 151959C
Authority
DK
Denmark
Prior art keywords
methylenoxyguanidine
halogenisoxazol
analogy
methyl
preparation
Prior art date
Application number
DK023087A
Other languages
English (en)
Other versions
DK151959B (da
DK23087A (da
Inventor
Rezso Bognar
Istvan Pelyvas Ferenczik
Ferenc Sztaricskai
Zoltan Gyoergydeak
Jozsef Szegi
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of DK23087A publication Critical patent/DK23087A/da
Publication of DK151959B publication Critical patent/DK151959B/da
Application granted granted Critical
Publication of DK151959C publication Critical patent/DK151959C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK023087A 1980-03-19 1987-01-16 Analogifremgangsmaade til fremstilling af 3-methyl-4-halogenisoxazol-5-yl-methylenoxyguanidin eller farmakologisk acceptable syreadditionssalte deraf DK151959C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU63780 1980-03-19
HU8080637A HU180567B (en) 1980-03-19 1980-03-19 Method for producing derivatives of isooxazole

Publications (3)

Publication Number Publication Date
DK23087A DK23087A (da) 1987-01-16
DK151959B DK151959B (da) 1988-01-18
DK151959C true DK151959C (da) 1988-07-11

Family

ID=10950573

Family Applications (3)

Application Number Title Priority Date Filing Date
DK122581A DK151012C (da) 1980-03-19 1981-03-18 Analogifremgangsmaade til fremstilling af 3-methyl-4-halogen-5-aminooxymethyl-isoxazoler eller et syreadditionssalt deraf
DK023087A DK151959C (da) 1980-03-19 1987-01-16 Analogifremgangsmaade til fremstilling af 3-methyl-4-halogenisoxazol-5-yl-methylenoxyguanidin eller farmakologisk acceptable syreadditionssalte deraf
DK023187A DK153549C (da) 1980-03-19 1987-01-16 Analogifremgangsmaade til fremstilling af 3-methyl-4-halogen-5-bromethylaminomethylisoxazoler eller farmakologisk acceptable syreadditionssalte deraf

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK122581A DK151012C (da) 1980-03-19 1981-03-18 Analogifremgangsmaade til fremstilling af 3-methyl-4-halogen-5-aminooxymethyl-isoxazoler eller et syreadditionssalt deraf

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK023187A DK153549C (da) 1980-03-19 1987-01-16 Analogifremgangsmaade til fremstilling af 3-methyl-4-halogen-5-bromethylaminomethylisoxazoler eller farmakologisk acceptable syreadditionssalte deraf

Country Status (15)

Country Link
JP (1) JPS56158774A (da)
BE (1) BE887954A (da)
CA (1) CA1163631A (da)
CH (1) CH646157A5 (da)
DE (1) DE3110817A1 (da)
DK (3) DK151012C (da)
ES (3) ES8302674A1 (da)
FI (1) FI70011C (da)
FR (1) FR2478634A1 (da)
GB (1) GB2075009B (da)
HU (1) HU180567B (da)
IT (1) IT1211010B (da)
SE (1) SE454695B (da)
SU (3) SU1053750A3 (da)
YU (1) YU42560B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0979226B1 (en) * 1997-04-21 2005-11-09 Sumitomo Pharmaceuticals Company, Limited Isoxazole derivatives
US6100260A (en) * 1997-04-21 2000-08-08 Sumitomo Pharmaceutical Company, Limited Isoxazole derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL302496A (da) * 1962-12-22
US3808221A (en) * 1971-04-14 1974-04-30 Hoffmann La Roche Antiandrogenic n-(3,5-dilower alkyl-4-heterocyclic)methyl)phthalimides

Also Published As

Publication number Publication date
ES511895A0 (es) 1983-05-01
DK151959B (da) 1988-01-18
HU180567B (en) 1983-03-28
SU1158044A3 (ru) 1985-05-23
DK23187A (da) 1987-01-16
ES501095A0 (es) 1983-02-16
FR2478634B1 (da) 1983-11-10
DK151012B (da) 1987-10-12
JPS56158774A (en) 1981-12-07
GB2075009A (en) 1981-11-11
SE8101703L (sv) 1981-09-20
YU68981A (en) 1983-10-31
DK153549B (da) 1988-07-25
ES511894A0 (es) 1984-01-01
FI70011B (fi) 1986-01-31
DK151012C (da) 1988-07-04
YU42560B (en) 1988-10-31
DK122581A (da) 1981-09-20
GB2075009B (en) 1983-11-30
FI810838L (fi) 1981-09-20
ES8305340A1 (es) 1983-05-01
SU1053750A3 (ru) 1983-11-07
IT1211010B (it) 1989-09-29
CA1163631A (en) 1984-03-13
FR2478634A1 (fr) 1981-09-25
SE454695B (sv) 1988-05-24
DE3110817A1 (de) 1982-03-04
ES8401758A1 (es) 1984-01-01
DK23087A (da) 1987-01-16
ES8302674A1 (es) 1983-02-16
IT8120395A0 (it) 1981-03-18
DK153549C (da) 1988-12-05
CH646157A5 (en) 1984-11-15
BE887954A (fr) 1981-09-16
FI70011C (fi) 1986-09-12
SU1152518A3 (ru) 1985-04-23

Similar Documents

Publication Publication Date Title
DK462380A (da) Analogifremgangsmaade til fremstilling af 2,4-diaminoquinazolin-forbindelser eller syreadditionssalte deraf
DK144010C (da) Analogifremgangsmaade til fremstilling af 2-piperazinyl-6,7-dimethoxyquinazoliner eller syreadditionssalte deraf
DK74282A (da) Fremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf
DK148795C (da) Anologifremgangsmaade til fremstilling af 3-(2-morpholino-ethyl-amino)-5-phenyl-pyridazin eller farmaceutisk acceptable syreadditionssalte deraf
DK217481A (da) Fremgangsmaade til fremstilling af pyridoxinderivater eller syreadditionssalte deraf
DK413783D0 (da) Fremgangsmade til fremstilling af 20-amino-macrolidderivater eller syreadditionssalte deraf
DK157862C (da) Analogifremgangsmaade til fremstilling af imidazolylphenylamidiner eller farmaceutisk acceptable syreadditionssalte deraf
DK453181A (da) Fremgangsmaade til fremstilling af 2-quanidino-4-heteroaryl-thiazolforbindelser eller syreadditionssalte deraf
DK160421C (da) Analogifremgangsmaade til fremstilling af 4-oxo-1,4-dihydronicotinsyrederivater eller salte deraf
DK334581A (da) Fremgangsmaade til frmstilling af 9-amino-1-hydroxyotahydro-6h-benzo (c) quinolin-derivater eller syreadditionssalte deraf
DK155792C (da) Analogifremgangsmaade til fremstilling af pyrrol-eddikesyreamider eller salte deraf
DK157451C (da) Analogifremgangsmaade til fremstilling af 2,4-diamino-6-alkoxybenzyl-5-methylpyridooe2,3-daapyrimidiner eller farmaceutisk acceptable syreadditionssalte deraf
DK146281C (da) Analogifremgangsmaade til fremstilling af 2-brom-6-fluor-n-2-imidazolidinyliden-benzamin eller syreadditionssalte heraf
DK321482A (da) Fremgangsmaade til fremstilling af 1-imidazolyl-2-phenyl-8-piperazinylphenoxy-octan-2-ol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK150597C (da) Analogifremgangsmaade til fremstilling af 3,4-bis-substituerede 1,2,5-oxadiazol-2-oxider eller farmakologisk acceptable syreadditionssalte deraf
DK438482A (da) Fremgangsmaade til fremstilling af indanderivater eller syreadditionssalte deraf
DK157135C (da) Analogifremgangsmaade til fremstilling af 1,2,4-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK148281C (da) Analogifremgangsmaade til fremstilling af 8a-substituerede 8,8a-desoxy-8,8a-dihydrooleandomycin-forbindelser eller farmaceutiskacceptable syreadditionssalte deraf
DK148903C (da) Analogifremgangsmaade til fremstilling af enkephalin-analoge pentapeptidderivater eller syreadditionssalte deraf
DK160875C (da) Analogifremgangsmaade til fremstilling af 3,7-diazabicyklooe3.3.1aa-nonanforbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK160043C (da) Analogifremgangsmaade til fremstilling af n-alk-2-en-4-yn-yl-benzothienylalkylaminer eller syreadditionssalte deraf
DK553982A (da) Fremgangsmaade til fremstilling af omt-esterderivater eller syreadditionssalte deraf
DK148036C (da) Analogifremgangsmaade til fremstilling af epimere 4''-amino-erythromycin-forbindelser eller syreadditionssalte deraf
DK151959C (da) Analogifremgangsmaade til fremstilling af 3-methyl-4-halogenisoxazol-5-yl-methylenoxyguanidin eller farmakologisk acceptable syreadditionssalte deraf
DK151021C (da) Analogifremgangsmaade til fremstilling af 17,18-dehydro-apovincaminol-3',4',5'-trimethoxybenzoat eller farmaceutisk acceptable syreadditionssalte deraf

Legal Events

Date Code Title Description
PBP Patent lapsed